KaloBios Pharma (KBIO) CEO Shkreli to Stop Lending Out Shares

KaloBios Pharma (Nasdaq: KBIO) shares are up around 50 percent in early trading Friday as CEO Martin Shkreli said he would stop lending out the company's shares. The following was posted to Twitter on Thursday:

I spoke with my counsel & advisers and decided to stop lending my $KBIO shares out until I better understand the advantages of doing so. 1/2

— Martin Shkreli (@MartinShkreli) November 26, 2015

I apologize for any inconvenience this may create in lending markets and I will probably resume lending at some point. Happy Thanksgiving!

— Martin Shkreli (@MartinShkreli) November 26, 2015

You May Also Be Interested In

• Alphabet (GOOGL) soars 16% on Q1 results beat, first-ever dividend
• IMAC Holdings (BACK) halted on volatility, up 38%
• Apple (AAPL) announces 'Let Loose,' a special online event to be held in May